Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Carl Zeiss Meditec (AFX) Stock Price & Analysis

AFX Stock Chart & Stats

CHF 32.04CHF 0.00(0.00%)
At close: 5:30 PM GMT+1
CHF50CHF100CHF15015 Mar6 Oct12 Jan20 Mar7 Apr6 Oct
Day’s Range
CHF 31.64 - CHF 33.24
52-Week Range
CHF 20.86 - CHF 174.60
Previous Close
CHF 32.04
Volume
0
Average Volume (3M)
18
Market Cap
CHF 2.88B
Enterprise Value
CHF 2.72B
Total Cash (Recent Filing)
CHF 23.90M
Total Debt (Recent Filing)
CHF 0
Price to Earnings (P/E)
20.9
Beta
0.18
Next Earnings
Dec 10, 2026 (Est.)
EPS Estimate
0.42
Next Dividend Ex-Date
N/A
Dividend Yield
1.52%

Bulls Say, Bears Say

Bulls Say

Balance Sheet Strength

Low leverage and a robust equity ratio provide Carl Zeiss Meditec with financial resilience. This supports continued investment in ophthalmology and microsurgery products, gives management flexibility during weaker demand, and reduces the balance-sheet pressure associated with funding operations or growth.

Operating Cash Generation

Positive operating cash flow indicates that the company is converting reported earnings into cash and can support ongoing operations internally. The stable cash-flow-to-net-income relationship strengthens confidence in cash generation, even as management must address weaker free cash flow growth.

Medical Technology Positioning

Carl Zeiss Meditec operates across several specialized medical technology categories, including eye diagnostics, cataract and refractive surgery, glaucoma, retinal care, and microsurgery. This focused portfolio gives the business exposure to multiple clinical applications and supports a durable position in professional healthcare equipment.

Bears Say

Revenue Growth Pressure

The reported negative revenue-growth measure signals current top-line pressure and raises questions about near-term demand, commercial execution, or the pace of procedure-related equipment purchases. If sustained, slower sales would limit operating leverage and make future profit recovery more difficult.

Margin Compression

Declining net profit, EBIT, and EBITDA margins show that strong gross profitability is not fully translating into operating and bottom-line earnings. Persistent margin compression could reduce the company’s ability to fund innovation, absorb cost increases, and convert revenue growth into durable earnings growth.

Free Cash Flow Weakness

Weaker free cash flow growth indicates that less cash is being retained relative to earnings, potentially reducing internally funded investment capacity. Although operating cash flow remains positive, this deterioration can constrain product development, strategic initiatives, and shareholder returns if it persists.

Carl Zeiss Meditec News

AFX FAQ

What was Carl Zeiss Meditec’s price range in the past 12 months?
Carl Zeiss Meditec lowest stock price was CHF20.86 and its highest was CHF174.60 in the past 12 months.
What is Carl Zeiss Meditec’s market cap?
Carl Zeiss Meditec’s market cap is CHF2.88B.
When is Carl Zeiss Meditec’s upcoming earnings report date?
Carl Zeiss Meditec’s next earnings report is estimated for Dec 10, 2026 (not yet confirmed), which is in 38 days.
How were Carl Zeiss Meditec’s earnings last quarter?
Carl Zeiss Meditec released its earnings results on Aug 06, 2026. The company reported CHF0.497 earnings per share for the quarter, beating the consensus estimate of CHF0.378 by CHF0.12.
Is Carl Zeiss Meditec overvalued?
According to Wall Street analysts Carl Zeiss Meditec’s price is currently Overvalued.
Does Carl Zeiss Meditec pay dividends?
Carl Zeiss Meditec does not currently pay dividends.
What is Carl Zeiss Meditec’s EPS estimate?
Carl Zeiss Meditec’s EPS estimate is 0.42.
How many shares outstanding does Carl Zeiss Meditec have?
Carl Zeiss Meditec has 89,440,570 shares outstanding.
What happened to Carl Zeiss Meditec’s price movement after its last earnings report?
Carl Zeiss Meditec reported an EPS of CHF0.497 in its last earnings report, beating expectations of CHF0.378. Following the earnings report the stock price went down -0.915%.
Which hedge fund is a major shareholder of Carl Zeiss Meditec?
Currently, no hedge funds are holding shares in CH:AFX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology